Immunoglobulin heavy variable 3-22 (IGHV3-22)

Immunoglobulin heavy variable 3-22 (IGHV3-22) refers to a *germline gene segment* within the immunoglobulin heavy chain locus on chromosome 14 that encodes a variable (V) domain of the antigen-binding heavy chain of antibodies[1][4]. Like other IGHV segments, IGHV3-22 participates in V(D)J recombination to generate the enormous diversity of B cell receptors (membrane-bound immunoglobulins) and secreted antibodies, which are central to adaptive immunity[1]. The IGHV3 family is one of several families of IGHV gene segments, but IGHV3-22 itself is typically classified as a **pseudogene** in the human genome[3]. This means it does not produce a functional antibody heavy chain variable region in most individuals due to sequence defects. IGHV3-22 is not a classical drug target, receptor, or enzyme, and there are no known drugs, mechanisms of drug action, or approved biomarkers related specifically to IGHV3-22. Its main relevance is in genetic and immunological studies of antibody diversity and repertoire. **Rationale for "is_incorrect":** IGHV3-22, by HGNC/IMGT convention, is a germline gene segment (typically a pseudogene in the human genome) and not a standalone protein target, receptor, or direct therapeutic target. The gene segment serves as a genetic building block for antibody structural diversity and not as a functional entity itself[3][1]. References to "IGHV3-22" as a single target should be treated with caution, as its functional product, if any, is realized only after recombination and is extremely context-specific. For most practical and therapeutic target mapping tasks, IGHV genes are not considered actionable targets.

Other names

3-22PIGHV322IGHV3-22